Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Multiple Myeloma peptide trials
18 selected ClinicalTrials.gov records carrying the official condition label Multiple Myeloma. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
18 selected records.
2 profiles.
2017–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 34 selected PubMed records and 7 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Multiple Myeloma unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT03606577
PeptideScanner retained ClinicalTrials.gov record NCT03606577 at 2026-11-17T13:28:01.467Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was carfilzomib.
- PeptideScanner change date
- November 17, 2026
- Cited source date
- November 12, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT06152575
PeptideScanner retained ClinicalTrials.gov record NCT06152575 at 2026-11-17T13:28:01.467Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was carfilzomib.
- PeptideScanner change date
- November 17, 2026
- Cited source date
- November 12, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT07555938
PeptideScanner retained ClinicalTrials.gov record NCT07555938 at 2026-11-17T13:28:01.467Z. Its registry update date was 2026-11-10, and PeptideScanner's reviewed identity mapping was carfilzomib.
- PeptideScanner change date
- November 17, 2026
- Cited source date
- November 10, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Carfilzomib · 2026-11-12
ClinicalTrials.gov record NCT03606577
Active, not recruiting at the retained observation.
Open attributed record →Carfilzomib · 2026-11-12
ClinicalTrials.gov record NCT06152575
Recruiting at the retained observation.
Open attributed record →Carfilzomib · 2026-11-10
ClinicalTrials.gov record NCT07555938
Recruiting at the retained observation.
Open attributed record →Carfilzomib · 2026-11-02
ClinicalTrials.gov record NCT05497804
Active, not recruiting at the retained observation.
Open attributed record →Carfilzomib · 2026-10-06
ClinicalTrials.gov record NCT04430894
Active, not recruiting at the retained observation.
Open attributed record →Carfilzomib · 2026-09-29
ClinicalTrials.gov record NCT01559935
Completed at the retained observation.
Open attributed record →Motixafortide · 2026-07-23
ClinicalTrials.gov record NCT07101445
Recruiting at the retained observation.
Open attributed record →Carfilzomib · 2026-05-29
ClinicalTrials.gov record NCT03290950
Active, not recruiting at the retained observation.
Open attributed record →Carfilzomib · 2026-03-20
ClinicalTrials.gov record NCT02773030
Active, not recruiting at the retained observation.
Open attributed record →Carfilzomib · 2026-03-10
ClinicalTrials.gov record NCT01572480
Completed at the retained observation.
Open attributed record →Carfilzomib · 2026-01-16
ClinicalTrials.gov record NCT02969837
Completed at the retained observation.
Open attributed record →Carfilzomib · 2025-11-20
ClinicalTrials.gov record NCT02937571
Completed at the retained observation.
Open attributed record →Motixafortide · 2025-08-29
ClinicalTrials.gov record NCT06547112
Completed at the retained observation.
Open attributed record →Carfilzomib · 2025-04-29
ClinicalTrials.gov record NCT03412565
Completed at the retained observation.
Open attributed record →Carfilzomib · 2022-11-14
ClinicalTrials.gov record NCT01568866
Completed at the retained observation.
Open attributed record →Carfilzomib · 2022-09-23
ClinicalTrials.gov record NCT02412878
Completed at the retained observation.
Open attributed record →Carfilzomib · 2019-08-26
ClinicalTrials.gov record NCT01818752
Completed at the retained observation.
Open attributed record →Carfilzomib · 2017-05-02
ClinicalTrials.gov record NCT01302392
Completed at the retained observation.
Open attributed record →